Reif, Andreas
Goethe University Frankfurt · Fraunhofer Institute for Translational Medicine and Pharmacology · University Hospital Frankfurt
74 papers on CoChatORCID 0000-0002-0992-634X
Most cited papers
- Verified
Co-morbidity of adult attention-deficit/hyperactivity disorder with focus on personality traits and related disorders in a tertiary referral center
Jacob, C. P., Romanos, J., Dempfle, A., Heine, M., Windemuth-Kieselbach, C., Kruse, A., Reif, A., Walitza, S., Romanos, M., Strobel, A., et al. (2007) · European Archives of Psychiatry and Clinical Neuroscience
Attention Deficit Hyperactivity DisorderPersonality Disorders and Psychopathology
Cited by 237
- Verified
Esketamine Nasal Spray versus Quetiapine for Treatment-Resistant Depression
Reif, A., Bitter, I., Buyze, J., Cebulla, K., Frey, R., Fu, D.-J., Ito, T., Kambarov, Y., Llorca, P.-M., Oliveira-Maia, A. J., et al. (2023) · New England Journal of Medicine
Treatment of Major DepressionElectroconvulsive Therapy Studies
Cited by 222
- Verified
Subcortical brain volume, regional cortical thickness, and cortical surface area across disorders: findings from the ENIGMA ADHD, ASD, and OCD working groups
Boedhoe, P. S. W., van Rooij, D., Hoogman, M., Twisk, J. W. R., Schmaal, L., Abe, Y., Alonso, P., Ameis, S. H., Anikin, A., Anticevic, A., et al. (2020) · American Journal of Psychiatry
Attention Deficit Hyperactivity DisorderAutism Spectrum Disorder Research
Cited by 201
- Verified
Oxytocin receptor gene methylation: converging multilevel evidence for a role in social anxiety
Ziegler, C., Dannlowski, U., Bräuer, D., Stevens, S., Laeger, I., Wittmann, H., Kugel, H., Dobel, C., Hurlemann, R., Reif, A., et al. (2015) · Neuropsychopharmacology
Neuroendocrine regulation and behaviorAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes
Cited by 193
- Verified
Multicenter Analysis of the SLC6A3/DAT1 VNTR Haplotype in Persistent ADHD Suggests Differential Involvement of the Gene in Childhood and Persistent ADHD
Franke, B., Vasquez, A. A., Johansson, S., Hoogman, M., Romanos, J., Boreatti-Hümmer, A., Heine, M., Jacob, C. P., Lesch, K.-P., Casas, M., et al. (2010) · Neuropsychopharmacology
Attention Deficit Hyperactivity DisorderNeurotransmitter Receptor Influence on Behavior
Cited by 183
- Verified
MAOA gene hypomethylation in panic disorder-reversibility of an epigenetic risk pattern by psychotherapy
Ziegler, C., Richter, J., Mahr, M., Gajewska, A., Schiele, M. A., Gehrmann, A., Schmidt, B., Lesch, K.-P., Lang, T., Helbig-Lang, S., et al. (2016) · Translational Psychiatry
Epigenetics and DNA MethylationAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes
Cited by 183
- Verified
Deficiency of brain 5-HT synthesis but serotonergic neuron formation in Tph2 knockout mice
Gutknecht, L., Waider, J., Kraft, S., Kriegebaum, C., Holtmann, B., Reif, A., Schmitt, A., & Lesch, K.-P. (2008) · Journal of Neural Transmission
Neurotransmitter Receptor Influence on BehaviorNeurogenesis and neuroplasticity mechanisms
Cited by 173
- Verified
Genome-wide copy number variation analysis in attention-deficit/hyperactivity disorder: association with neuropeptide Y gene dosage in an extended pedigree
Lesch, K.-P., Selch, S., Renner, T. J., Jacob, C., Nguyen, T. T., Hahn, T., Romanos, M., Walitza, S., Shoichet, S., Dempfle, A., et al. (2011) · Molecular Psychiatry
Genomic variations and chromosomal abnormalitiesAttention Deficit Hyperactivity Disorder
Cited by 167
- Verified
GWAS meta-analysis of suicide attempt: identification of 12 genome-wide significant loci and implication of genetic risks for specific health factors
Docherty, A. R., Mullins, N., Ashley-Koch, A. E., Qin, X., Coleman, J. R. I., Shabalin, A., Kang, J., Murnyak, B., Wendt, F., Adams, M., et al. (2023) · American Journal of Psychiatry
Genetic Associations and EpidemiologySuicide and Self-Harm Studies
Cited by 160
- Verified
High Loading of Polygenic Risk for ADHD in Children With Comorbid Aggression
Hamshere, M. L., Langley, K., Martin, J., Agha, S. S., Stergiakouli, E., Anney, R. J. L., Buitelaar, J., Faraone, S. V., Lesch, K.-P., Neale, B. M., et al. (2013) · American Journal of Psychiatry
Attention Deficit Hyperactivity DisorderGenetic Associations and Epidemiology
Cited by 144
- Verified
Neurobiological markers predicting treatment response in anxiety disorders: A systematic review and implications for clinical application
Lueken, U., Zierhut, K. C., Hahn, T., Straube, B., Kircher, T., Reif, A., Richter, J., Hamm, A., Wittchen, H.-U., & Domschke, K. (2016) · Neuroscience & Biobehavioral Reviews
Anxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesNeurotransmitter Receptor Influence on Behavior
Cited by 133
- Verified
Monoamine oxidase A gene DNA hypomethylation - A risk factor for panic disorder?
Domschke, K., Tidow, N., Kuithan, H., Schwarte, K., Klauke, B., Ambrée, O., Reif, A., Schmidt, H., Arolt, V., Kersting, A., et al. (2012) · The International Journal of Neuropsychopharmacology
Epigenetics and DNA MethylationAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes
Cited by 132
- Verified
Long-term lithium treatment in bipolar disorder: effects on glomerular filtration rate and other metabolic parameters
Tondo, L., Abramowicz, M., Alda, M., Bauer, M., Bocchetta, A., Bolzani, L., Calkin, C. V., Chillotti, C., Hidalgo-Mazzei, D., Manchia, M., et al. (2017) · International Journal of Bipolar Disorders
Bipolar Disorder and TreatmentSchizophrenia research and treatment
Cited by 125
- Verified
Shared genetic background between children and adults with attention deficit/hyperactivity disorder
Rovira, P., Demontis, D., Sánchez-Mora, C., Zayats, T., Klein, M., Mota, N. R., Weber, H., Garcia-Martínez, I., Pagerols, M., Vilar-Ribó, L., et al. (2020) · Neuropsychopharmacology
Attention Deficit Hyperactivity DisorderGenetic Associations and Epidemiology
Cited by 111
- Verified
Microglia ablation alleviates myelin-associated catatonic signs in mice
Janova, H., Arinrad, S., Balmuth, E., Mitjans, M., Hertel, J., Habes, M., Bittner, R. A., Pan, H., Goebbels, S., Begemann, M., et al. (2017) · Journal of Clinical Investigation
Neuroinflammation and Neurodegeneration MechanismsTryptophan and brain disorders
Cited by 107
- Verified
Anxiety, mood, and substance use disorders in adult men and women with and without attention-deficit/hyperactivity disorder: A substantive and methodological overview
Hartman, C. A., Larsson, H., Vos, M., Bellato, A., Libutzki, B., Solberg, B. S., Chen, Q., Du Rietz, E., Mostert, J. C., Kittel-Schneider, S., et al. (2023) · Neuroscience & Biobehavioral Reviews
Attention Deficit Hyperactivity DisorderSubstance Abuse Treatment and Outcomes
Cited by 104
- Verified
A functional dopamine-β-hydroxylase gene promoter polymorphism is associated with impulsive personality styles, but not with affective disorders
Hess, C., Reif, A., Strobel, A., Boreatti-Hümmer, A., Heine, M., Lesch, K.-P., & Jacob, C. P. (2009) · Journal of Neural Transmission
Neurotransmitter Receptor Influence on BehaviorAttention Deficit Hyperactivity Disorder
Cited by 104
- Verified
Alcohol use disorders and ADHD.
Luderer, M., Ramos Quiroga, J. A., Faraone, S. V., Zhang-James, Y., & Reif, A. (2021) · Neuroscience & Biobehavioral Reviews
Attention Deficit Hyperactivity DisorderSubstance Abuse Treatment and Outcomes
Cited by 102
- Verified
Effect of Minocycline on Depressive Symptoms in Patients With Treatment-Resistant Depression: A Randomized Clinical Trial
Hellmann-Regen, J., Clemens, V., Grözinger, M., Kornhuber, J., Reif, A., Prvulovic, D., Goya-Maldonado, R., Wiltfang, J., Gruber, O., Schüle, C., et al. (2022) · JAMA Network Open
Treatment of Major DepressionTryptophan and brain disorders
Cited by 100
- Verified
Genetics of ADHD: What Should the Clinician Know?
Grimm, O., Kranz, T. M., & Reif, A. (2020) · Current Psychiatry Reports
Attention Deficit Hyperactivity DisorderGenetic Associations and Epidemiology
Cited by 97
- Verified
Direct medical costs of ADHD and its comorbid conditions on basis of a claims data analysis
Libutzki, B., Ludwig, S., May, M., Jacobsen, R. H., Reif, A., & Hartman, C. A. (2019) · European Psychiatry
Attention Deficit Hyperactivity DisorderHealth Systems, Economic Evaluations, Quality of Life
Cited by 94
- Verified
Epigenetic signature of panic disorder: A role of glutamate decarboxylase 1 (GAD1) DNA hypomethylation?
Domschke, K., Tidow, N., Schrempf, M., Schwarte, K., Klauke, B., Reif, A., Kersting, A., Arolt, V., Zwanzger, P., & Deckert, J. (2013) · Progress in Neuro-Psychopharmacology and Biological Psychiatry
Epigenetics and DNA MethylationAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes
Cited by 87
- Verified
Evidence for cognitive subgroups in bipolar disorder and the influence of subclinical depression and sleep disturbances
Volkert, J., Kopf, J., Kazmaier, J., Glaser, F., Zierhut, K. C., Schiele, M. A., Kittel-Schneider, S., & Reif, A. (2015) · European Neuropsychopharmacology
Bipolar Disorder and TreatmentSchizophrenia research and treatment
Cited by 83
- Verified
Longitudinal multi-level biomarker analysis of BDNF in major depression and bipolar disorder
Schröter, K., Brum, M., Brunkhorst-Kanaan, N., Tole, F., Ziegler, C., Domschke, K., Reif, A., & Kittel-Schneider, S. (2020) · European Archives of Psychiatry and Clinical Neuroscience
Treatment of Major DepressionBipolar Disorder and Treatment
Cited by 68
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free